President of Venice Arrhythmias discusses current challenges in atrial fibrillation management

Antonio Raviele (Venice, Italy), the president of Venice Arrhythmias 2019 (3–5 October; Venice, Italy), talks to BLearning Cardio about some of the current challenges in atrial fibrillation (AF) management, which he notes include lifestyle modification and risk factor modification and the risk to stop oral anticoagulation after an apparently successful AF ablation.

He also outlines what he believes are the “three most controversial aspects” in the field of cardiac arrhythmia at the moment. One of these, says Raviele, is the question of when silent AF justifies the start of oral anticoagulation. The other controversies include whether “we should switch all patients on Coumadin to DOACs” (direct oral anticoagulants) and whether AF ablation really reduces hard endpoints such as cardiac mortality and stroke.

Raviele, Antonio

Antonio Raviele is one of the Presidents of Venice Arrhythmias – the worldwide-known workshop he actually created back in 1989. After graduating with honours in Medicine and Surgery from the University of Naples in 1971, he specialised in Cardiology at the University of Florence in 1974.

He was previously the Chief of the Cardiology Division and Chief of the Cardiovascular Department of the Umberto I Hospital of Mestre – Venice, in Italy. He is now retired and works as cardiologist and arrhythmologist in his private office in Mestre-Venice.

Raviele is also the President of ALFA – the Aliance to Fight Atrial fibrillation – and President of the Scientific Committee of the FIGHT AF! awareness campaign. He has also played key roles within many cardiology associations and societies – such as ECAS, ESC and HRS.

Add comment

Editor’s Cardiovascular Pick

    Subscribeto receive the very best in medical videos